Robert Hershberg Nano String Technologies Inc (NSTG) insider trading activity

Robert Hershberg is Director of NanoString Technologies Inc. Currently has a direct ownership of 10,716 shares of NSTG, which is worth approximately $0. The most recent transaction as insider was on Apr 18, 2022, when has been sold 3,306 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7K

0% 3M change

0% 12M change

Total Value Held $0

ROBERT HERSHBERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 18 2022	BUY Exercise of conversion of derivative security	-	3,306 Added 23.58%	10,716 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	-	5,520 Added 42.69%	7,410 Common Stock
Apr 15 2021	SELL Open market or private sale	$10,503 $72.94 p/Share	144 Reduced 7.08%	1,890 Common Stock
Apr 15 2021	BUY Exercise of conversion of derivative security	$2,118 $14.71 p/Share	144 Added 6.61%	2,034 Common Stock
Mar 15 2021	SELL Open market or private sale	$98,385 $65.59 p/Share	1,500 Reduced 44.25%	1,890 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$16,800 $11.2 p/Share	1,500 Added 30.67%	3,390 Common Stock
Feb 16 2021	SELL Open market or private sale	$96,430 $81.17 p/Share	1,188 Reduced 38.6%	1,890 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$13,306 $11.2 p/Share	1,188 Added 27.85%	3,078 Common Stock
Jan 15 2021	SELL Open market or private sale	$109,830 $73.22 p/Share	1,500 Reduced 44.25%	1,890 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$16,800 $11.2 p/Share	1,500 Added 30.67%	3,390 Common Stock
Dec 15 2020	SELL Open market or private sale	$103,920 $69.28 p/Share	1,500 Reduced 44.25%	1,890 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$16,800 $11.2 p/Share	1,500 Added 30.67%	3,390 Common Stock
Nov 16 2020	SELL Open market or private sale	$70,005 $46.67 p/Share	1,500 Reduced 44.25%	1,890 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	$16,800 $11.2 p/Share	1,500 Added 30.67%	3,390 Common Stock
Oct 15 2020	SELL Open market or private sale	$58,860 $39.24 p/Share	1,500 Reduced 44.25%	1,890 Common Stock
Oct 15 2020	BUY Exercise of conversion of derivative security	$16,800 $11.2 p/Share	1,500 Added 30.67%	3,390 Common Stock

Also insider at

FATE

FATE THERAPEUTICS INC Healthcare

Director

RXRX

RECURSION PHARMACEUTICALS, INC. Healthcare

Director

ADPT

Adaptive Biotechnologies Corp Healthcare

Director

SBTX

Silverback Therapeutics, Inc. Healthcare

Director

HLVX

HilleVax, Inc. Healthcare